Dr. Singh is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
9500 Gilman Dr
# Mail
La Jolla, CA 92093Phone+1 619-543-2347Fax+1 858-657-7259
Education & Training
- Mayo Clinic College of Medicine and Science (Rochester)Fellowship, Gastroenterology, 2011 - 2014
- University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 2008 - 2011
- All India Institute of Medical SciencesClass of 2007
Certifications & Licensure
- CA State Medical License 2015 - 2025
- MN State Medical License 2011 - 2016
- IA State Medical License 2008 - 2011
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Clinical Trials
- Pharmacologic Weight Loss as Adjunct Therapy for Ulcerative Colitis in Obese Patients Start of enrollment: 2020 Dec 18
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Network Meta-Analysis: Comparison of Endoscopic Dysplasia Detection Technologies in Inflammatory Bowel Disease.Mohammad Shehab, Ahmed Al-Hindawi, Fatema Alrashed, Sanjay Murthy, Raf Bisschops
Alimentary Pharmacology & Therapeutics. 2025-03-01 - Correction to: Medical Therapies for Prevention and Treatment of Inflammatory Pouch Disorders-A Systematic Review and Meta-Analysis.Gaurav Syal, Edward Barnes, Laura Raffals, Elie Al Kazzi, John Haydek
The American Journal of Gastroenterology. 2025-02-17 - Responsiveness of different disease activity indices in moderate-to-severe ulcerative colitis.Virginia Solitano, Remo Panaccione, Bruce E Sands, Zhongya Wang, Malcolm Hogan
Med. 2025-02-14
Journal Articles
- Comparison of Multiplex Gastrointestinal Pathogen Panel and Conventional Stool Testing for Evaluation of Diarrhea in Patients with Inflammatory Bowel DiseasesWaseem Ahmad, Daniel Bouland, Nghia H Nguyen, David T Pride, Siddharth Singh, Parambir S Dulai, William J Sandborn, Brigid S Boland, Digestive Diseases and Sciences
- No Benefit of Concomitant 5-Aminosalicylates in Patients with Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data from Cli...Siddharth Singh, Parambir S Dulai, William J Sandborn, Nature
- Obesity and Response to Infliximab in Patients with Inflammatory Bowel Diseases: Pooled Analysis of Individual Participant Data from Clinical TrialsSiddharth Singh, William J Sandborn, Nature
Press Mentions
- New CGH Special Issue: The Future of IBD CareFebruary 20th, 2025
- List of Advanced Rx Recommended For Moderate to Severe UC ExpandsFebruary 4th, 2025
- New AGA Living Guideline Expands Recommended Drugs for Moderate to Severe UCNovember 26th, 2024
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: